A CPAP built around you.

Reimagining positive airway pressure for obstructive sleep apnea.

Get in touchIn development · not currently available for sale
What we’re building

A device that adapts.

Rhythm is building a positive airway pressure (PAP) device designed to sense subtle airway collapse and adjust pressure proactively to prevent respiratory events before they happen.

Origin story

We’ve been there.

Many of us at Rhythm have lived this story. Your sleep test comes back, but you don’t meet the strict diagnostic criteria for OSA. You keep searching, trying whatever you read about online. Nothing makes you feel rested. Then you learn about upper airway resistance syndrome (UARS): frequent respiratory disturbances — an elevated RDI — and finally a name for what you have.

Or maybe, like others here, you are diagnosed. You’re prescribed a CPAP and hope it will finally restore your energy and mental clarity. Night after night, you can’t tolerate it. Your equipment supplier is little help.

PAP therapy is the gold standard, and the least invasive option there is. Yet most people abandon their device within a year,1–3 if they receive one at all. Uncomfortable pressure and poor support push people off a treatment with life-changing potential.

We’ve lived both stories. We’re fixing both failures — the device and the ecosystem around it. And we measure success the way you do: not by numbers from a sleep report, but by how you feel awake.

A Rhythm cofounder wearing a CPAP mask and finger sensors, seated behind a table covered with CPAP machines, masks, nasal sprays, and other sleep apnea treatments
All of the treatments one cofounder tried before starting Rhythm
Get in touch

Let’s talk.

Partner, investor, or simply curious — we’d love to hear from you.

hello@rhythmpap.com

References

  1. Baratta F, Pastori D, Bucci T, et al. Long-term prediction of adherence to continuous positive air pressure therapy for the treatment of moderate/severe obstructive sleep apnea syndrome. Sleep Med. 2018;43:66-70. doi:10.1016/j.sleep.2017.09.032
  2. Chai-Coetzer CL, Luo YM, Antic NA, et al. Predictors of long-term adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea and cardiovascular disease in the SAVE study. Sleep. 2013;36(12):1929-1937. doi:10.5665/sleep.3232
  3. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc. 2008;5(2):173-178. doi:10.1513/pats.200708-119MG